pocketful logo
Hester Biosciences Ltd logo

Hester Biosciences Ltd

NSE: HESTERBIO BSE: 524669

₹1646.30

(0.51%)

Tue, 12 May 2026, 01:31 pm

Hester Biosciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    1479.47

  • Net Profit

    28.83

  • P/B

    3.39

  • Sector P/E

    34.27

  • P/E

    38.81

  • EV/EBITDA

    18.42

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.95

  • ROCE (Industry)

    16.47

  • RONW (Industry)

    14.44

  • ROE

    9.51

  • ROCE

    8.86

  • Debt/Equity

    0.76

  • EPS (TTM)

    48.13

  • Dividend Yield

    0.40

  • Book Value

    397.22

  • Interest Cover

    4.12

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4.4x coverage).
  • Hester Biosciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Hester Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Hester Biosciences is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Hester Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Hester Biosciences's level of debt (56.5%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.
  • Rajiv's remuneration is higher than average for companies of similar size in India.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters53.7353.7353.7353.7353.73
FII0.380.510.530.040.87
DII0.000.010.000.020.02
Public45.8945.7545.7446.2045.38
Government00000

Read More

Technical Analysis

RSI

64.26

MACD

62.74

50 DMA

1495.57

200 DMA

1677.84

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2619.732094.731864.471569.731339.471044.73519.73
Fibonacci2094.731894.181770.281569.731369.181245.281044.73
Camarilla1778.581730.451682.331569.731586.081537.951489.83

Pivots Level: Classic

R3

+1050.00

2619.73

R2

+525.00

2094.73

R1

+294.73

1864.47

1569.73
1569.73
Pivot Point
LTP: 1695

S1

-230.27

1339.47

S2

-525

1044.73

S3

-1050

519.73

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1650.71

  • 20-EMA

    1597.80

  • 30-EMA

    1565.25

  • 50-EMA

    1538.99

  • 100-EMA

    1553.40

  • 200-EMA

    1634.86

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 Jan 2026board-meetingsQuarterly Results
11 Jul 2025agm
06 Jul 2025dividendFinal Dividend - Rs. - 706 Aug 2025
09 May 2025dividend₹7.00 Dividend /Share06 Aug 2025
26 Jul 2024agm
22 Jul 2024dividendDividend - Rs 6 Per Share22 Aug 2024
22 Jul 2024agmAnnual General Meeting23 Aug 2024
10 May 2024dividend₹6.00 Dividend /Share23 Aug 2024
23 Aug 2023agm
13 Aug 2023dividendAnnual General Meeting/Dividend - Rs 8 Per Share14 Sept 2023

Read More

Peer Comparison

Hester Biosciences Ltd logo

Hester Biosciences Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Hester Biosciences Ltd About

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1987

Headquarters

CEO

Bhupendra V Gandhi

Employees

Contact

Website icon

Website

http://www.hester.in

Email icon

Email

investor@hesterbiosciences.co.in

Phone icon

Phone

91-079-26445107

Location icon

Location

1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Read More

Hester Biosciences Ltd Company History

YearHistory
2013
  • Hester Biosciences received WHO GMP Certification.
  • Hester launched Bivalent Marek's Disease Live Vaccine.
2014
  • Hester Biosciences board approved a scheme of amalgamation.
  • The Company recommended a dividend of Rs. 2.00 per equity share of Rs. 10 each for the financial year 2013-14.
2015
  • Hester Biosciences launched PPR vaccine and Goat Pox vaccine.
2020
  • Hester Nepal launched the thermo-tolerant PPR Vaccine.
2021
  • Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
HESTER COATINGS PRIVATE LIMITEDSell90000732.122 Mar 2017
RAJIV DINESH GANDHIBuy90000732.122 Mar 2017
K PAL JOYSell4780027621 Aug 2014
SHIRIN DHUNJISHAW GHANDHISell60000171.801 Jul 2014
PIYUSH BATUKBHAI DAVEBuy50000110.2324 Jun 2013
PIYUSH BATUKBHAI DAVESell50000110.6724 Jun 2013
JASHWANT JAGMOHAN SHAHSell2850512622 Aug 2012
VIRAJBEN SIDDHARTHBHAI PATELBuy2850512622 Aug 2012
N K PROTEINS LTDBuy35000125.1521 May 2012
VIMAL RAMNIKLAL AMBANISell35000125.1521 May 2012

Read More

Hester Biosciences Ltd News

Hester Biosciences Q4 & FY2026 Earnings Call Set for May 15

Hester Biosciences has scheduled its Q4 & FY2026 earnings conference call for May 15, 2026, at 2:00 p.m. IST, facilitated by ICICI Securities.

12 May 2026

companies

Hester Biosciences Q4 & FY2026 Earnings Call Set for May 15

Hester Biosciences has scheduled its Q4 & FY2026 earnings conference call for May 15, 2026, at 2:00 p.m. IST, facilitated by ICICI Securities.

11 May 2026

companies

Hester Biosciences Board Meeting on May 15

Hester Biosciences Limited has scheduled a Board meeting for May 15, 2026, to consider audited financial results for FY26 and potential dividend declaration.

08 May 2026

companies

Hester Biosciences Declares No Encumbrance by Promoters

Hester Biosciences Limited files regulatory declaration confirming promoters and promoter group made no encumbrances during FY26 ended March 31, 2026, as required under SEBI regulations.

24 Apr 2026

companies

Hester Biosciences submits quarterly compliance report

Hester Biosciences Limited submitted confirmation certificate for securities dematerialised/rematerialised during quarter ended 31 March 2026 under SEBI Depositories Regulations to stock exchanges.

08 Apr 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800